| Literature DB >> 21349700 |
John D Chodera1, David L Mobley, Michael R Shirts, Richard W Dixon, Kim Branson, Vijay S Pande.
Abstract
Improved rational drug design methods are needed to lower the cost and increase the success rate of drug discovery and development. Alchemical binding free energy calculations, one potential tool for rational design, have progressed rapidly over the past decade, but still fall short of providing robust tools for pharmaceutical engineering. Recent studies, especially on model receptor systems, have clarified many of the challenges that must be overcome for robust predictions of binding affinity to be useful in rational design. In this review, inspired by a recent joint academic/industry meeting organized by the authors, we discuss these challenges and suggest a number of promising approaches for overcoming them.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21349700 PMCID: PMC3085996 DOI: 10.1016/j.sbi.2011.01.011
Source DB: PubMed Journal: Curr Opin Struct Biol ISSN: 0959-440X Impact factor: 6.809